Search Results Search Sort by RelevanceMost Recent Viewpoint Dec 2002 The Twelve Days of Christmas Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):370-371. doi: 10.1001/virtualmentor.2002.4.12.dykn1-0212. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. In the Literature Oct 2002 Should Clinician-Researchers Disclose Financial Incentives to Patients? Jeremy Spevick Virtual Mentor. 2002;4(10):299-301. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210. Podcast Dec 2022 Author Interview: “Solidarity in Mortal Time” Dr Helen Stanton Chapple joins Ethics Talk to discuss her article: "Solidarity in Mortal Time.” Medicine and Society Dec 2022 Solidarity in Mortal Time Helen Stanton Chapple, PhD, RN, MSN, MA The concept of mortal time is useful for exploring how hospice care frameworks might help nonhospice clinicians find calm in practice. AMA J Ethics. 2022;24(12):E1149-1154. doi: 10.1001/amajethics.2022.1149. Case and Commentary Aug 2005 Finding the (Right) Time: Physician-to-Drug Rep Communication Michael E. Roloff, PhD and Rachel Malis, MA Virtual Mentor. 2005;7(8):554-558. doi: 10.1001/virtualmentor.2005.7.8.ccas5-0508. Viewpoint Nov 1999 The Value of Industry Gifts to Physicians Audiey Kao, MD, PhD Virtual Mentor. 1999;1(3):21-22. doi: 10.1001/virtualmentor.1999.1.3.dykn1-9911. Case and Commentary Feb 2013 Quality Improvement of Economic Profiling Marguerite Huff Virtual Mentor. 2013;125-130. doi: 10.1001/virtualmentor.2013.15.2.bndr2-1302. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. AMA Code Says Jul 2003 The Code on Physicians' Relationship with Industry Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):263-264. doi: 10.1001/virtualmentor.2003.5.7.code1-0307. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »
Viewpoint Dec 2002 The Twelve Days of Christmas Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):370-371. doi: 10.1001/virtualmentor.2002.4.12.dykn1-0212.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
In the Literature Oct 2002 Should Clinician-Researchers Disclose Financial Incentives to Patients? Jeremy Spevick Virtual Mentor. 2002;4(10):299-301. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210.
Podcast Dec 2022 Author Interview: “Solidarity in Mortal Time” Dr Helen Stanton Chapple joins Ethics Talk to discuss her article: "Solidarity in Mortal Time.”
Medicine and Society Dec 2022 Solidarity in Mortal Time Helen Stanton Chapple, PhD, RN, MSN, MA The concept of mortal time is useful for exploring how hospice care frameworks might help nonhospice clinicians find calm in practice. AMA J Ethics. 2022;24(12):E1149-1154. doi: 10.1001/amajethics.2022.1149.
Case and Commentary Aug 2005 Finding the (Right) Time: Physician-to-Drug Rep Communication Michael E. Roloff, PhD and Rachel Malis, MA Virtual Mentor. 2005;7(8):554-558. doi: 10.1001/virtualmentor.2005.7.8.ccas5-0508.
Viewpoint Nov 1999 The Value of Industry Gifts to Physicians Audiey Kao, MD, PhD Virtual Mentor. 1999;1(3):21-22. doi: 10.1001/virtualmentor.1999.1.3.dykn1-9911.
Case and Commentary Feb 2013 Quality Improvement of Economic Profiling Marguerite Huff Virtual Mentor. 2013;125-130. doi: 10.1001/virtualmentor.2013.15.2.bndr2-1302.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
AMA Code Says Jul 2003 The Code on Physicians' Relationship with Industry Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):263-264. doi: 10.1001/virtualmentor.2003.5.7.code1-0307.